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In 2007, the International Agency for Research on Cancer classified shift work involving circadian disruption 
as probably carcinogenic to humans (group 2A), primarily based on experimental and epidemiologic evidence 
for breast cancer. In order to examine options for evidence-based preventive actions, 16 researchers in basic, 
epidemiological and applied sciences convened at a workshop in Copenhagen 26–27 October 2011. This paper 
summarizes the evidence from epidemiological and experimental studies and presents possible recommendations 
for prevention of the effects of night work on breast cancer.
Among those studies that quantified duration of shift work, there were statistically significant elevations 
in risk only after about 20 years working night shift. It is unclear from these studies whether or not there is a 
modest but real elevated risk for shorter durations. Hence, restriction of the total number of years working night 
shift could be one future preventive recommendation for shift workers. The diurnal secretion of melatonin by 
the pineal gland with peak in secretory activity during the night is a good biochemical marker of the circadian 
rhythm. Disruption of the diurnal melatonin secretion pattern can be diminished by restricting the number of 
consecutive night shifts. Reddish light and reduced light intensity during work at night could potentially help 
diminish the inhibitory activity of light with strong intensity on the melatonin secretion, but further mechanistic 
insight is needed before definite recommendations can be made. Earlier or more intensive mammography screen-
ing among female night shift worker is not recommended because the harm–benefit ratio in this age group may 
not be beneficial. Preventive effects of melatonin supplementation on breast cancer risk have not been clearly 
documented, but may be a promising avenue if a lack of side effects can be shown even after long-term inges-
tion. Women with previous or current breast cancer should be advised not to work night shifts because of strong 
experimental evidence demonstrating accelerated tumor growth by suppression of melatonin secretion.
Work during the night is widespread worldwide. To provide additional evidence-based recommendations 
on prevention of diseases related to night shift work, large studies on the impact of various shift schedules and 
type of light on circadian rhythms need to be conducted in real work environments. 
Key terms   circadian rhythm; melatonin; occupational disease; night work; prevention; shift work. 
1 Department of Occupational and Environmental Medicine, Bispebjerg Hospital, University of Copenhagen, Denmark.
2 Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark.
3 Danish Ramazzini Centre, Department of Occupational Medicine, Aarhus University Hospital, Aarhus, Denmark.
4  Department of Structural & Cellular Biology, School of Medicine, Tulane University, New Orleans, Louisiana, USA.
5 Centre of Expertise on Human Factors at Work, Finnish Institute of Occupational Health, Helsinki, Finland.
6 Department of Occupational Medicine and Epidemiology, National Institute of Occupational Health, Oslo, Norway.
7 Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
8 Department of Epidemiology, University of California, Los Angeles, USA
9 Aarhus Universitet, Institut for Epidemiologi og Socialmedicin, University of Aarhus, Aarhus, Denmark.
10 Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
11 Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA.
12 Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
13 Division of Epidemiology & Biostatistics, Department of Community and Health Care, University of Connecticut Health Center, Farmington, 
USA.
14 Institute for Stress Research, Stockholm University and Karolinska Institutet, Stockholm, Sweden.
Correspondence to: Jens Peter Bonde, Department of Occupational and Environmental Medicine, Bispebjerg University Hospital, Bispebjerg 
Bakke 23, DK-2400 Copenhagen NV, Denmark. [E-mail: jpb@bbh.regionh.dk]
 Scand J Work Environ Health 2012, vol 38, no 4 381
Bonde et al
About 15–20% of employees in Europe and USA work 
night shifts and an increasing segment of the working 
population in industrialized countries worldwide work 
non-day shifts (1). In 2007, the International Agency for 
Research on Cancer (IARC) classified shift work that 
involves circadian disruption as “probably carcinogenic 
to humans” (group 2A) (2, 3). This conclusion was based 
on (i) sufficient evidence in animal studies for carcino-
genicity of light during the daily dark period, (ii) strong 
experimental data suggestive of a causal link between cir-
cadian disruption and development of malignant tumors 
and (iii) limited epidemiological evidence of increased 
risk of breast cancer among women working night shifts. 
In Denmark, exposures classified by the IARC as 
carcinogenic to humans (group 1) or probably carcino-
genic to humans (group 2A) are considered for inclu-
sion in the list of occupational diseases. Between 2007 
and 2011, the Danish National Board of Occupational 
Injuries recognized some 110 cases of breast cancer as 
diseases caused by work at night and therefore eligible 
for compensation. Assuming that work at night indeed 
contributes to the occurrence of human breast cancer 
and considering the high prevalence of night work, it 
has become an important priority to examine if current 
knowledge allows for evidence-based recommendations 
of preventive actions. For this purpose, 16 researchers 
in biological, epidemiological and applied sciences 
convened at a workshop in Copenhagen, 26–27 October 
2011. This report provides a brief account of background 
information, conclusions and recommendations that 
emerged from the workshop. While increasing evidence 
on shift work and cancer risk prompted the workshop, it 
is acknowledged that preventive measures should also 
accommodate other known and suspected health risks 
related to shift work such as sleep disorders, accidents, 
cardiovascular disease, and metabolic disorders (4). This 
paper, however, deals with breast cancer only.  
Light, circadian rhythms, and melatonin
Circadian rhythms are evident in virtually all living 
animals and plants. They are genetically encoded and 
adjusted to local time primarily by an entrainment to the 
daily photoperiod via light reaching the eye. Circadian 
rhythms (including, for example, sleep/wake cycles, 
body temperature, blood pressure, hormone secretion, 
digestion, metabolism, and cell turnover) are pivotal 
for survival and driven and maintained in a hierarchi-
cal manner by a central pacemaker (the biologic master 
clock) located in the suprachiasmatic nucleus (SCN) of 
the hypothalamus. The SCN also orchestrates the inde-
pendent peripheral clocks in the rest of the  organism into 
a coherent time organization with optimal time structure 
and biological function for the entire body (5).  The 
endogenous clockwork is entrained to the ambient diurnal 
light/dark cycle given by the rotation of the earth in rela-
tion to the sun, primarily through photosensitive retinal 
ganglion cells containing the newly detected photopig-
ment melanopsin (peak sensitive to blue light of 460–484 
nm). It transmits time of day, duration of the day, and day 
of year information to the pineal gland by the SCN and 
the sympathetic nerve system (6). From the pineal gland, 
the time information is signaled to organs and tissues by 
secretion of the neurohormone melatonin – a lipophilic 
indole – and binding to cell membrane-bound melatonin 
receptors. Melatonin is produced during the biological 
night (from dusk to dawn), whereas the daytime produc-
tion is virtually zero. While the peak of the melatonin 
secretion signals time relative to the astronomical 24-hour 
light/dark cycle, the duration of the melatonin surge indi-
cates the length of the day, and indirectly the time of the 
year (season). Exposure to light during night immediately 
reduces melatonin production dependent of light intensity, 
wavelength and duration of exposure, and may in addi-
tion cause desynchronization of the master clock from 
the peripheral clocks, including the fine-tuned circadian 
gene expression in local tissues and cells (7–9). During 
the last decades, melatonin receptors have been shown to 
be present in several peripheral tissues outside the brain 
and also in neoplasms of the mammary gland.
In the scientific literature, the term “circadian dis-
ruption” is defined as desynchronization of internal 
circadian rhythms relative to ambient dark/light cycle, 
including desynchronization of the SCN with periph-
eral clocks. Circadian disruption is partly but not fully 
characterized by change in physiological markers of the 
circadian rhythm such as amplitude, duration, and tim-
ing of melatonin secretion. In a broader sense, circadian 
disruption describes objective or subjective proxies of 
changed circadian rhythm (such as sleep disturbance and 
tiredness). In this paper, the term is used in the broader 
meaning, unless otherwise specified, recognizing that 
little is known about the relation between real life shift 
work and physiological markers of circadian rhythm.
The vast majority of experimental evidence sup-
ports the hypothesis that under the conditions of com-
plete darkness, high circulating levels of melatonin 
during the night not only provide a potent circadian 
anti-cancer signal to established cancer cells but also 
help to protect normal cells from the initiation of the 
carcinogenic process in the first place (7, 8). Most of 
the earlier studies using experimental models of either 
spontaneous or chemically induced rodent models of 
mammary carcinogenesis demonstrate an accelerated 
development of mammary tumors in response to expo-
sure to constant bright fluorescent light at night. More 
recent  experimental work demonstrates that chronically 
advancing the phasing of light exposure (chronic jet 
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lag) plays a significant role in malignant progression in 
tumor-bearing mice (10). Thus a change of the timing 
of the light/dark cycle by steady phase advances in light 
exposure may represent a potentially important biologi-
cal mechanism for increased cancer growth.
Studies of female rats bearing human breast cancer 
xenografts show that growth and metabolic activity of 
tumors increase significantly as the intensity of light 
exposure increases, and that these effects are caused 
by a corresponding suppression of nocturnal melatonin 
secretion. Moreover, mechanistic evidence indicates that 
the ability of the nocturnal melatonin to suppress tumor 
fatty acid uptake and metabolism, particularly linoleic 
acid, is compromised by circadian disruption (8). This 
experimental evidence provides a link between exposure 
of healthy human female subjects to light at night and 
enhancement of human breast oncogenesis via suppres-
sion of the nocturnal melatonin anti-cancer signal.  The 
suppression of melatonin production by exposure to 
light at night, leading to augmented tumor growth and 
linoleic uptake/metabolism deserves serious consider-
ation as a potential biological mechanism to explain the 
association between breast cancer and night shift work.
Melatonin is the most stable and reliable biological 
marker of circadian rhythm in humans and therefore 
information on how shift systems and light exposure 
affects melatonin homeostasis is important when consid-
ering options for preventive actions (11). Four out of five 
prospective cohort studies among women without night 
work have shown increased risk of breast cancer related to 
low urine levels of the melatonin metabolite, 6-sulfatox-
ymelatonin in morning spot samples or 24 hour samples 
(12–16). Unfortunately there are only few studies that in 
some detail outline the melatonin exposure profile (peak, 
amplitude, duration, timing) among people working night 
shifts (17–20) except among nurses working in fast-
forward-rotating shifts (21). These studies report a small 
reduction (typically less than 20%) in melatonin secretion 
and a flattened secretion profile among night compared to 
day workers. Changes seemed more pronounced among 
permanent night workers but were also found for other 
shift workers after the night shift (18). Although light with 
wavelength 460–480 nm creates the strongest suppression 
of melatonin (22), even dim red light causes suppression; 
work in constant dim red light is hardly a realistic option 
since most work tasks require better lighting conditions 
for safety and productivity reasons.
The IARC evaluation in 2007
The IARC evaluation included three cohort studies 
(two of them prospective) and five case–control studies 
addressing the risk of breast cancer in relation to various 
definitions of non-day work, including evening, night, 
and early morning shifts as defined by self-reports or 
estimated from job exposure matrices (23–30). Six of the 
eight studies showed increased relative risk in the range 
of 1.4–2.2 when extreme categories of non-day work 
were compared (23–28). Data on the overall relative 
risk for breast cancer according to uniform definitions 
of night shift work cannot be directly obtained from the 
studies. Moreover, eight of nine cohort studies of flight 
attendants – who may be exposed to both jetlag, cosmic 
radiation, and shift work – reported increased risk of 
breast cancer (3). Other studies addressing risk of breast 
cancer in occupations with a high prevalence of night 
work were not included in the IARC evaluation. All 
three studies of nurses reported significantly increased 
risk for breast cancer for night shift work beyond 20–30 
years in the range of 1.4–2.2 (24–26). 
Update of the epidemiologic evidence
Since the IARC evaluation, four additional observa-
tional studies have been published, three of which were 
case–control studies (31–33) and one cohort study (34). 
In general these studies tended to cover more details 
concerning shift systems (eg, rotating versus permanent 
shift and number of consecutive shifts) compared to 
the older studies, which in particular focused on dura-
tion. Two case–control studies nested within cohorts of 
nurses indicate an association between night shift work 
and breast cancer after adjustment for most known 
potential confounders (32, 33). In the Lie et al study 
(32), an increased risk is observed among nurses with 
≥5 consecutive night shifts during ≥5 years, while in 
the Hansen & Stevens study (33) an increased risk is 
observed even after a short duration of night shift work. 
The two other studies indicated no overall effect of 
night shift work (31, 34), but the Pesch et al study (31) 
reported a non-significantly increased risk with cumu-
lative number of night shifts. None of the studies had 
sufficient power to stratify on different histologic sub-
types of breast cancer or age of onset for breast cancer 
(eg, pre-, postmenopausal cancer). Only one of the four 
studies adjusted for participation in breast cancer screen-
ing activities. Uncontrolled confounding by screening 
could potentially contribute to underestimation of risk 
of breast cancer if screening is less frequent among night 
workers, which is indicated by some data (31). This is 
because screening not only detects cancer at an earlier 
stage but also breast cancers that would not progress 
to clinical detection. An overview of breast cancer risk 
according to non-day shift work is provided in table 1 
based upon the 12 epidemiological studies included in 
this report.
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A main limitation of epidemiological studies so far 
is uncertainty in how best to define work schedules and 
crude quantification of work at night across studies. 
Thus, exposure misclassification in studies using expo-
sure matrices may diminish exposure contrasts, thereby 
reducing the ability to identify effects whereas recall 
bias in the case–control studies may generate a spurious 
association or overestimate a true risk. Further limita-
tions are uncertain exposure–response relationships and 
findings restricted to few specific occupations (ie, nurs-
ing) in 5 out of 12 studies.
How to prevent circadian disruption? 
Disruption of the circadian rhythm is assumed to be a 
main pathway from shift work to disease, although other 
mechanisms may also be involved (35). This applies 
not only to risk of cancer but also to other known and 
suspected shift-work-related disorders (1). Complete 
elimination of work at night is not foreseeable in either 
low- or high-income countries. Therefore it is important 
to identify and implement shift systems that minimize 
circadian disruption and other factors that might be 
involved in carcinogenicity such as behavioral and 
lifestyle factors.   
The degree of circadian adjustment varies signifi-
cantly in relation to shift schedules, although the evi-
dence is still limited (36–39). Factors influencing the 
degree of circadian disruption are mostly related to spe-
cific shift characteristics like timing, speed (ie, number 
of consecutive night shifts), duration and direction of 
shift rotation as well as factors related to the actual light 
exposure (intensity, wavelength and timing). On the 
other hand, also individual factors (eg, diurnal prefer-
ence and sleep pattern) and other environmental factors 
(eg, eating and lighting when not at work) influence the 
circadian adjustment. 
Cumulative number of years working nightshifts
Setting limits to the total lifelong “work at night” dose 
in analogy with guidelines on cumulative radiation dose 
would be justified if reliable knowledge on cancer risk 
in relation to cumulative night work exposure were 
available. For those studies that quantified duration, 
statistically significant increases in risk were only seen 
for ≥20 years; but it is unclear from the existing studies 
whether or not there is risk for shorter durations (table 
1). Overall there is no clear pattern of increased risk with 
increasing number of years working at night. Moreover, 
a threshold value separating risk and no-risk cannot cur-
rently be identified.   
Cumulative number of night shifts
Night shift work per se is not expected to be a risk 
factor of breast cancer but is an upstream cause for 
light-at-night exposure, melatonin suppression, circa-
dian phase shift, and sleep deprivation, which may be 
more proximal determinants of breast cancer. In any 
case, one would expect that breast cancer risk increases 
as the cumulative number of nightshifts increase (40, 
41). Since the cumulative number of night shifts was 
analyzed using different metrics in the six epidemio-
logical studies addressing this issue (27, 28, 31–34), 
the consistency of results cannot be evaluated without 
access to raw data.    
Number of consecutive night shifts
An alternative strategy to diminish circadian disruption 
is to minimize the number of consecutive nightshifts 
in order to prevent circadian adjustment and maximize 
recovery to the normal day-oriented sleep/wake rhythm. 
Even rapidly rotating shifts may cause sleep deprivation 
and should therefore be organized with between-shift 
periods of sufficient duration to allow for full recovery 
in terms of rest and sleep (42). Based on most studies 
and recommendations, the use of forward-rotating shift 
systems (1–2 consecutive night shifts) seems to be more 
favorable for sleep, performance, and the social life of 
the workers than the use of more slowly rotating shift 
rotations (3–5 consecutive nightshifts) (4, 36, 37, 42). 
Rapidly forward-rotating shift systems also suit older 
workers better because of their shortened day sleep after 
a night shift and hence decreased adjustment to consecu-
tive night shifts (42, 43). 
Epidemiologic evidence indicating that working 
slowly rotating shift systems (working consecutively 
4–5 or more nights) is related to a higher risk of breast 
cancer has only been reported in one study (32) and 
indirectly in another study reporting the highest breast 
cancer risk among nurses with periods of both perma-
nent night shifts and rotating shifts compared to nurses 
with rotating shifts only (33). 
Number of nightshifts per month
One early study (31) showed an increased risk of breast 
cancer with increasing average number of night shifts 
per month but two later studies did not (32, 34).
Working permanent night shifts
Since most permanent night shift workers return to a 
normal diurnal rhythm during days off, they are not 
expected to have a risk for breast cancer that differs 
from workers on rotating night shift work beyond the 
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potential effect of number of shifts. However, little is 
known about differences between specific night shift 
schedules in relation to the cumulated melatonin excre-
tion, eg, if permanent night shift differs from slow- or 
fast-rotating shifts with respect to cumulated melatonin 
secretion over a longer time period with the same num-
ber of night shifts. So far, only one study has reported 
risk for breast cancer for permanent and rotating night-
shifts separately (33). In remote work sites, it may be 
feasible to combine permanent nightshifts with a switch 
of the day/night rhythm during days off work and thus 
achieve circadian readjustment over extended periods 
of time. Detailed measures of melatonin across different 
work shift periods in longitudinal cohorts are warranted. 
Intensity of light at night 
Experimental studies show that white light provides a 
strong signal to the brain centre regulating the circadian 
rhythm and produces the most pronounced suppression 
of melatonin secretion from the pineal gland (the maxi-
mum effect in the blue end of the spectrum, ie, at wave 
length 460–480 nm) (44, 45). Thus, exposure to bright 
white light during night shifts may be used to stimulate 
adaptation to night work, if desirable (46) (eg, for per-
manent night workers), but bright white light should be 
avoided if such adaptation is not desirable (eg, in fast-
rotation shifts where dim red light is preferable when 
possible and safe considering the work tasks). Similarly, 
permanent night shift workers should avoid bright light 
after work (eg, by using dark sun-glasses) and return 
home to sleep, while fast-rotating shift workers should 
be exposed to the morning bright light in order not to 
change the normal circadian rhythm. Bright light expo-
sure during the first half of the biological night (before 
the melatonin peak) will delay the circadian rhythm, 
and bright light exposure during the latter half, after 
the melatonin peak, will advance the rhythm (47). The 
effects of implementation of light exposure regimens to 
delay or advance the circadian rhythm may therefore be 
unpredictable at the individual level, depending on their 
circadian phase when they are exposed to light. Large 
intervention studies are needed before specific light 
exposure regimens are recommended for night shifts in 
different types of shifts. 
Nutritional issues
Dietary factors may influence cancer growth and 
metabolism (48). Experimental evidence indicates that 
melatonin partly exerts its anti-proliferative effects by 
inhibiting uptake of linoleic acid (an essential omega-6 
polyunsatturated acid) into the cells (8). There is, how-
ever, no human evidence to indicate ameliorating effects 
of specific diets during night work relative to cancer or 
other disease risks. Recommendations for a healthy diet 
to the general population also apply for night shift work-
ers until good research indicates otherwise. 
Rest and short sleep periods during night shifts
It is well established that shift work at night is related 
to poor sleep quality and shorter sleep duration (49), 
and the latter has been associated with increased risk 
for breast cancer (50). Periods of rest and “power naps” 
during night shifts can increase alertness but there is no 
evidence that power naps reduce circadian disruption or 
prevent breast cancer.
Vulnerability in shift work 
There is no available data on vulnerability to cancer 
among shift workers but several studies have examined 
individual factors related to outcomes such as being able 
to cope with shift work, fatigue, and sleepiness (51). 
Factors like aging and being predisposed to an earlier 
circadian phase (“morningness”) decrease the speed 
of adaptation to consecutive night shifts. Eveningness 
compared to morningness seems to facilitate permanent 
night work, but not rotating shift work. Shift workers 
who are transferred to day work become more morning 
types. During the last few years, there has been some 
focus on the shift work disorder: sleep or alertness prob-
lems supposedly characterizing individuals working at 
night but the prevalence of these disorders among day 
workers is unknown. 
Research into clock genes and other genes of impor-
tance for circadian rhythm is at an early stage (52) and 
so far there is no reliable genetic test that can identify 
persons who are more sensitive to circadian disruption 
than others. In general, primary or secondary preventive 
action independent of individual genetic disposition is 
recommended since the working environment should be 
organized to suit all workers.
Mammography screening
Breast cancer screening is offered to the female popu-
lation in the age range 50–74 years in many countries 
regardless of risk status. Extending breast cancer screen-
ing to pre-menopausal women working night shifts has 
been considered. However, the harm–benefit ratio is 
higher among women <50 years unless a very strong risk 
factor (eg, first line family occurrence) is present. Con-
sidering the magnitude of risk related to work at night (if 
any, a relative risk ≤2), it is not justified to recommend 
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Table 1. Shift–work and breast cancer risk studies in chronology order by duration and cumulative number of nights. [ND=not determined; 
RR=relative risk; 95% CI=95% confidence interval; P–value=test for trend]
Study 
(country)
Study  
design 
(period)
Non-day time work  
exposure definition
Duration of non-daytime work Cumulative night shift
Exposure 
categories
Cases 
(N)
RR 95% CI P- 
value
Exposure 
categories
Cases 
(N)
RR 95% CI P- 
value
Tynes et al, 
1996 
(Norway)
Nested case–
control study 
on naval radio 
telegraph op-
erators 
(1961–91)
Frequent present in radio 
room both at night and 
during the day
All
<50 years 
  None 
  >0–3.2 years 
  3.2–14.6 years
≥50 year 
  None 
  >0–3.2 years 
  3.2–14.6 years
50
 
3 
13 
13
 
1 
5 
15
1.5
 
1 
0.9 
0.8
 
1.0 
1.9 
5.9
1.1–2.0
 
reference 
0.2–3.7 
0.2–3.6
 
– 
0.2–17.9 
0.7–47.7
 
 
0.80
0.02
<50 years 
None 
Low 
High
≥50 years 
None 
Low 
High
 
12 
5 
29
 
3 
6 
12
 
1.0 
0.4 
0.9
 
1.0 
3.3 
6.1
 
reference 
0.1–1.2 
0.3–2.3
 
reference 
0.8–13.7 
1.5–24.2
 
 
0.87 
 
 
0.01
Hansen 2001, 
(Denmark)
Population- 
based nested 
case–control 
based on reg-
ister data 
(1964–94)
Working at least half 
a year at least 5 years 
prior to reference date 
in trades where at least 
60% of survey respond-
ers had non–day time 
schedules
Day time
All night work
>6 years
5847
434
117
1
1.5
1.7
reference
1.3–1.7
1.3–1.7
ND
Davis et al, 
2001, (USA)
Case–control 
(1992–95)
Graveyard shift: begin-
ning work after 19:00 
hours and leaving work 
before 09:00 hours
No graveyard 
shift 
Ever
 
Reference 
<3 
≥3 years 
 
Per year
713 
 
51
 
733 
15 
19 
 
767
1 
 
1.6
 
1 
1.3 
1.4 
 
1.13
reference 
 
1.0–2.5
 
reference 
0.6–3.2 
0.8–3.2 
 
1.01–1.27
 
0.04
Schernhammer 
et al 2001, 
(USA)
Prospective 
cohort of 
nurses  
(NHS I)  
(1988–98)
Rotating night shifts: 
years in total worked at 
least three nights per 
month in addition to 
days or evening in that 
month
Never
1–14 years
15–29 years
≥30 years
925
1324
134
58
1
1.1
1.1
1.4
reference
1.1–1.2
0.9–1.3
1.0–1.8
0.02
Schernhammer 
et al 2006, 
(USA)
Prospective 
cohort of 
nurses  
(NHS II) 
(1989–2001)
Rotating night shifts: 
total months worked  
for at least three nights 
per month in addition to 
days or evening in that 
month
Never
1–9 years
10–19 years
≥20 years
441
816
80
15
1
1.0
0.9
1.8
–
0.9–1.1
0.7–1.2
1.1–3.0
0.65
Lie et al, 2006 
(Norway)
Register 
based nested 
case–con-
trol study of 
nurses 
(1960–82)
Nurses working at  
infirmaries (hospitals)
0 years
>0–14 years
15–29 years
≥30 years
50
362
101
24
1
1.0
1.3
2.2
reference
0.7–1.3
0.8–2.0
1.1–4.5
0.01
O’Leary et al, 
2006 (USA)
Case–con-
trol study of 
workers 
(1996–97)
Evening work: starting 
afternoon and ending as 
late as 02:00 hours
Overnight work: starting 
as early as 19:00 hours 
and continue until the 
following morning
No evening or 
overnight shift 
work 
Evening shift 
only 
Overnight shift 
only
<1 evening  
shift/week 
<5 years  
evening shift 
≥5 years  
evening shift
<1 overnight 
shift/week 
<5 years  
evening shift 
≥5 years  
evening shift
313 
 
 
148 
 
10
 
356 
 
51 
 
79 
469 
 
11 
 
6 
 
1
1.2
0.6
1 
 
0.9 
 
1.2
 
1 
 
0.7 
 
0.3
reference
0.9–1.6
0.3–1.5
reference 
 
0.6–1.4 
 
0.9–1.8
 
reference 
 
0.3–1.7 
 
0.1–0.8
ND
continued
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Table 1. Continued
Study  
(country)
Study  
design 
(period)
Non-day time work  
exposure definition
Duration of non-daytime work Cumulative night shift
Exposure 
categories
Cases 
(N)
RR 95% CI P- 
value
Exposure 
categories
Cases 
(N)
RR 95% CI P- 
value
Schwartzbaum 
et al, 2007 
(Sweden)
Retrospective 
cohort of  
female par-
ticipants from 
censuses in 
1960 and 
1970 
(1971–89)
Occupation–industry 
combinations in which 
≥40% workers had a  
rotating schedule with 
≥3 possible shifts per 
day or had work hours 
during the night (any 
hour between 01:00–
04:00 hours) ≥1 day 
during the week
Shiftwork,  
census 1970
Census 1960  
and 1970
70
 
28
0.9
 
1.0
0.7–1.2
 
0.7–1.4
ND
Pesch et al, 
2008  
(Germany)
Population-
based case–
control 
(2000–2004)
Working the full–time 
period between 24.00–
05:00 hours for at least 
1 year
Employed,  
never shiftwork
Ever in  
night shift 
  >0–4 years 
  5–9 years 
  10–19 years 
  ≥20 years
698
 
55 
 
15 
11 
10 
12
1 
0.9 
 
0.7 
0.9 
0.8 
2.5
reference
 
0.6–1.5 
 
0.3–1.5 
0.3–2.8 
0.3–2.6 
0.6–10.0
 
ND
Employed, 
never in 
shiftwork
<1056 night  
shifts
≥056 night 
shifts
698
 
 
25
 
 
25
1
 
 
0.7
 
 
1.7
reference
 
 
0.3–1.3
 
 
0.7–4.2
 
 
ND
Pronk et al, 
2010 (China)
Prospective 
cohort 
(2000–2007)
Job exposure matrix 
score (0–3) for likelihood 
of night shift work 
 
Self report: starting 
work after 22:00 hours 
≥3 times a month for 
>1 year
0 
  >0–≤14 years 
  >14–≤25 years 
  >25 years
0 
  >0–≤5 years 
  >5–≤17 years 
  >17 years
423 
108 
89 
97
276 
25 
29 
19 
1 
1.1 
0.9 
1.0
1 
0.9 
0.9 
0.8
reference 
0.9–1.3 
0.7–1.1 
0.8–1.3
reference 
0.6–1.3 
0.6–1.4 
0.5–1.2
 
 
0.72 
 
 
0.26
0 
  >0–≤34  
  >34–≤66 
  >66
0 
  >0–≤576 
  >576–≤1632 
  >1632
423 
102 
103 
89
276 
27 
28 
18
1 
1.0 
1.0 
1.0
1 
0.9 
1.0 
0.7
reference 
0.8–1.3 
0.8–1.2 
0.8–1.2
reference 
0.6–1.3 
0.7–1.5 
0.4–1.1
 
 
0.84 
 
 
0.17
Lie et al 2011, 
(Norway)
Nested case– 
control study 
in cohort of 
nurses 
(1990–2007)
Permanent and rotating 
night schedules last-
ing from ≥24:00–06:00 
hours
Never night work
1–11 years
≥12 years
1
1.2
1.3
reference
0.9–1.5
0.9–1.8
0.17
Never night 
work
<1007  
night shifts
≥1007  
night shifts
<5 years  
night shift 
  ≥ 3 consecu-
tive shifts 
  ≥4 consecu-
tive shifts 
  ≥5 consecu-
tive shifts 
  ≥6 consecu-
tive shifts 
  ≥7 consecu-
tive shifts
≥5 years  
night shift 
  ≥3 consecu-
tive shifts 
 ≥4 consecu-
tive shifts 
  ≥5 consecu-
tive shifts 
  ≥6 consecu-
tive shifts 
  ≥7 consecu-
tive shifts
102 
396 
201
 
 
 
194 
 
160 
 
137 
 
119 
 
109 
 
 
278 
 
131 
 
74 
 
64 
 
58
1 
1.2 
1.2
1.1 
 
1.2 
 
1.2 
 
1.2 
 
1.1 
 
 
1.1 
 
1.4 
 
1.6 
 
1.8 
 
1.7
reference 
0.9–1.6 
0.9–1.7
0.8–1.6 
 
0.8–1.6 
 
0.8–1.7 
 
0.8–1.7 
 
0.8–1.6 
 
 
0.8–1.5 
 
0.9–1.9 
 
1.0–2.4 
 
1.1–2.8 
 
1.1–2.8
 
0.24
Hansen & 
Stevens 2011, 
(Denmark)
Nested case– 
control study 
in cohort of 
nurses 
(2001–2003)
About 8 hours work per 
day between 21:00–
07:00 hours for ≥1 year
Day and evening
1–5 years
5–10 years
10–20 years
≥20 years
Per year
37
55
70
66
39
267
1
1.5
2.3
1.9
2.1
1.02
reference
1.0–2.5
1.4–3.5
1.1–2.8
1.3–2.3
1.01–1.03
ND Day–evening
<468 night 
shifts
468–1095 
night shifts
≥1096 night 
shifts
37
63 
80 
87
1
1.6 
2.0 
2.2
reference
1.0–2.6 
1.3–3.0 
1.3–3.2
ND
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earlier or more intensive mammography screening to 
female night shift workers by means of present screen-
ing technology. The relatively higher harm–benefit ratio 
in younger women is the result of lower incidence of 
breast cancer, more false positive tests, and over diag-
nosing. Any risk due to ionizing radiation conferred by 
the screening procedure is marginal (53).  
Periodic health examinations
Benefits of periodic health examinations of night shift 
workers are not documented in the scientific literature 
(54). Periodic health examinations without defined and 
documented content may cause inappropriate health 
concern, increased burden on the healthcare system, and 
inappropriate use of resources (55, 56). The workshop 
acknowledges that there is a need for counseling of night 
shift workers regarding more general preventive lifestyle 
changes, but benefits from general health examinations 
are disputed.
Treatment with melatonin
From a theoretical point of view, the oncostatic effect 
of melatonin might be due to different mechanisms: 
(i) a direct binding of melatonin to the receptors in the 
tumor tissue, or (ii) an indirect effect via an entrain-
ment of the circadian clock in the SCN or a peripheral 
clock located in the tumor tissue itself (57). For the 
direct effect, a constant saturation of the receptor dur-
ing both day and night would be optimal. Contrarily, 
to phase-change the central or peripheral clock, a sin-
gle physiological melatonin dose should be given at a 
critical certain circadian time point, where the phase 
response of the circadian clock is maximal. Clinical 
treatments of cancer, including breast cancer, with 
large doses of melatonin given at bedtime, have been 
reported (58), but the value of such a treatment needs 
empirical support. Melatonin, taken orally, might or 
might not in the future be useful in the prevention of 
breast cancer among shift workers, and randomized 
controlled trials documenting beneficial effects on the 
circadian rhythm are warranted. Both long-term side 
effect as well as dose and circadian time point for the 
medication have to be determined. Investigations of 
neurotransmitters and receptors in the optic system 
transmitting light information to pineal gland might 
result in more effective future drugs than melatonin 
to restore normal circadian rhythms among shift 
workers.
Is breast cancer an occupational disease? 
The legal definition of an occupational disease and the 
criteria for recognition and worker compensation var-
ies profoundly between countries. Arguments in favor 
of recognizing breast cancer as an occupational disease 
include (i) an increasing number of epidemiologic studies 
reporting an association between breast cancer and shift 
work (including nightwork), and (ii) plausible mecha-
nisms linking work at night and breast cancer related to 
the disruption of circadian rhythms. Arguments against 
recognition raise the following shortcomings (i) weak 
associations limited to selected occupational groups, (ii) 
the poor definition of the nature of shift work, and (ii) 
unclear exposure–response relationships (59). The current 
scientific evidence, together with the large differences 
both in causal requirements and compensation systems 
between countries, does not allow for a global scientifi-
cally based recommendation to include (or not include) 
breast cancer in national lists of occupational diseases for 
compensation purposes. However, the scientific evidence 
of a potentially causal association between night work 
and breast cancer and the vast documentation of other 
detrimental health effects from shift work clearly calls for 
primary prevention, including a limitation of night work.
Concluding remarks and recommendations
Four epidemiologic studies published between 2008 and 
2011 provide no reason to revise the IARC’s conclusion 
that shift work involving circadian disruption is prob-
ably carcinogenic to humans 
In experimental animals, exposure to light during the 
biological night is strongly linked to an excess risk of 
tumors. This happens through a biological mechanism 
that may also operate in humans. In absence of sufficient 
human data, it is therefore prudent to regard night shift 
work that includes circadian disruption as carcinogenic.
Epidemiologic studies provide no clear pattern of 
increased risk with increasing number of years work-
ing at night, but studies that quantified the duration of 
shift work observed elevations in risk only after about 
20 years. Restriction of total number of night shifts or 
number of years working night shift may be considered, 
although current limited scientific evidence does not 
allow for more specific recommendations.
Options to limit circadian disruption
• Rapidly rotating shifts (1–2 consecutive nights) 
cause less disruption of circadian rhythms than 
slowly rotating shifts (≥3 consecutive shifts);
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• Delay of circadian phase causes less circadian 
disruption than advance of circadian phase and for 
this reason forward- rather than backward-rotating 
shifts are recommended;
• Permanent night work is an uncommon solution 
to avoid circadian disruption and is feasible in 
remote worksites where a night-oriented rhythm 
during days off is possible;
• Modified light intensity during work at night 
such as working in bright white light to increase 
adoption or in dim red light to prevent adoption 
may prove feasible methods to minimize circadian 
disruption, but further research on different light 
regimens is needed. This also includes studies 
addressing the optimal trade-off between effects 
on circadian rhythms and alertness;
• Considering the magnitude of increased risk 
related to work at night (if any) and because the 
harm–benefit ratio is unknown, it is at present not 
justified to offer earlier or more intensive mam-
mography screening to female night shift workers;
• Melatonin supplementation might in the future be 
useful in the prevention of breast cancer among 
shift workers, but randomized controlled trials 
documenting effects on the circadian rhythm and 
long-term side effects are needed before this is 
recommended. Both dose and circadian time point 
for the medication has to be determined;
• Current evidence does not allow a scientifically 
based recommendation to include (or exclude) 
breast cancer in national lists of occupational 
diseases for compensation purposes;
• Women with breast cancer should be advised not 
to work night shifts because of the strong experi-
mental evidence demonstrating that suppression 
of melatonin secretion causes augmented tumor 
growth; and
• The vast documentation of other detrimental 
health effects from shift work clearly calls for 
primary prevention including the limitation of 
night work.
In conclusion, the IARC classification calls for spe-
cific preventive actions. Considering the uncertainties 
in the scientific evidence, specific recommendations to 
regulate for example the number of years working night 
shifts, the number of consecutive nightshifts, or the 
specific spacing and number of night shifts in forward-
rotating shift work cannot be scientifically justified from 
the current knowledge. Decisions on specific preventive 
measures should be revised as new evidence becomes 
available.
Research needs
Work during the night is widespread and growing in 
developing countries. Therefore, understanding the 
specific risks associated with night work and their 
biological mechanisms of action are needed in order 
to minimize such risks on a scientific basis. Recently a 
working group identified several major domains of non-
day shifts and shift schedules that should be captured 
in future studies (shift system, duration working non-
day shifts, and shift intensity) (38). In order to provide 
more specific and evidence-based recommendations 
on the prevention of disease related to work at night, 
more research needs to be conducted on the impact of 
various shift schedules and the type of light and other 
exposures on melatonin and the circadian rhythms of 
workers in real-work environments (38). There is some 
evidence that long-term shift work leads to promoter 
methylation changes in specific circadian genes as well 
as whole genome wide alterations (60), and studies on 
epigenetic changes induced by shift work along the life 
course are needed.
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